Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of SGX945 (Dusquetide) in the Treatment of Aphthous Ulcers in Behcet's Disease

NCT06386744 is registered in ClinicalTrials.gov with Soligenix as lead sponsor.

NCT NCT06386744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06386744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of SGX945 (Dusquetide) in the Treatment of Aphthous Ulcers in Behcet's Disease
Lead sponsor
Soligenix
Phase
Phase 2
Overall status
Completed
Start date
November 18, 2024
Completion date
June 17, 2025
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

behçet disease